Overview
Kenji Morimoto practices practicing medicine in Kyoto, Japan.
Mr. Morimoto is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 86 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kenji Morimoto
Is Kenji Morimoto a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Kenji Morimoto is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kenji Morimoto participate in research or clinical trials?
Yes. Kenji Morimoto has published 86 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Kenji Morimoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Morimoto isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Morimoto isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Morimoto isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- AspergillosisMr. Morimoto isExperienced. Learn about Aspergillosis.
- EmphysemaMr. Morimoto isExperienced. Learn about Emphysema.
- Small Cell Lung Cancer (SCLC)Mr. Morimoto isExperienced. Learn about Small Cell Lung Cancer (SCLC).